Corticosteroid therapy for refractory infections in chronic granulomatous disease: Case reports and review of the literature

Annals of Allergy, Asthma and Immunology

Volumn 97, Issue 2, 2006, Pages 257-261

  Yamazaki Nakashimada, Marco A ^a   Stiehm, E Richard ^b   Pietropaolo Cienfuegos, Dino ^a   Hernandez Bautista, Victor ^a   Espinosa Rosales, Francisco ^a  

^a INSTITUTO NACIONAL DE PEDIATRÍA   (Mexico)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIINFECTIVE AGENT; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DICLOXACILLIN; ERYTHROMYCIN; FLUCONAZOLE; FLUCYTOSINE; GENTAMICIN; HYDROCORTISONE; IMIPENEM; ITRACONAZOLE; LEVOFLOXACIN; MEROPENEM; METHYLPREDNISOLONE; OXACILLIN; PREDNISOLONE; PREDNISONE; TETRACYCLINE;

ANTIMICROBIAL ACTIVITY; ASPERGILLUS; CASE REPORT; CHILD; CHRONIC DISEASE; CHRONIC GRANULOMATOUS DISEASE; CORTICOSTEROID THERAPY; FEMALE; HUMAN; IMMUNE DEFICIENCY; IMMUNE SYSTEM; MALE; PHAGOCYTE; PRIORITY JOURNAL; RECURRENT INFECTION; RESPIRATORY BURST; REVIEW;

EID: 33747691655     PISSN: 10811206     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1081-1206(10)60023-3     Document Type: Article

References (24)

1. Rosenzweig SD, Uzel G, Holland SM. Chronic granulomatous disease. In: Stiehm ER, Ochs H, Winkelstein J, eds. Immunologic Disorders in Infants and Children. 5th ed. Philadelphia, PA: Elsevier Saunders; 2004:620-629.
2. Fischer A, Segal AW, Seger R, et al. The management of chronic granulomatous disease. Eur J Pediatr. 1993;152:896-899.
3. Chin TW, Stiehm ER, Faloon J, Gallin JI. Corticosteroids in treatment of obstructive lesions of chronic granulomatous disease. J Pediatr. 1987;111:349-352.
4. Marciano BE, Rosenzweig SD, Kleiner DE, et al. Gastrointestinal involvement in chronic granulomatous disease. Pediatrics. 2004;114:462-468.
5. Danziger RN, Goren AT, Becker J, Greene JM, Douglas SD. Outpatient management with oral corticosteroid therapy for obstructive conditions in chronic granulomatous disease. J Pediatr. 1993;122:303-305.
6. Narita M, Shibata M, Togashi T, Tomizawa K, Matsumoto S. Steroid therapy for bronchopneumonia in chronic granulomatous disease. Acta Paediatr Jpn. 1991;33:181-185.
7. Okano M, Yamada M, Ohtsu M, et al. Successful treatment with methylprednisolone pulse therapy for a life-threatening pulmonary insufficiency in a patient with chronic granulomatous disease following pulmonary invasive aspergillosis and Burkholderia cepacia infection. Respiration. 1999;66:551-554.
8. Moltyaner Y, Geerts WH, Chamberlain DW, et al. Underlying chronic granulomatous disease in a patient with bronchocentric granulomatosis. Thorax. 2003;58:1096-1098.
9. Trawick D, Kotch A, Matthay R, Homer RJ. Eosinophilic pneumonia as presentation of occult chronic granulomatous disease. Eur Respir J. 1997;10:2166-2170.
10. Eppinger TM, Greenberger PA, White DA, Brown AE, Cunningham-Rundles C. Sensitization to Aspergillus species in the congenital neutrophil disorders chronic granulomatous disease and hyper-IgE syndrome. J Allergy Clin Immunol. 1999;104:1265-1272.
11. Kelly JK, Pinto AR, Whitelaw WA, Rorstad OP, Bowen TJ, Matheson DS. Fatal Aspergillus pneumonia in chronic granulomatous disease. Am J Clin Pathol. 1986;86:235-240.
12. Barrot E, Ortega-Calvo M, Borderas F, Sanchez J, Melero-Ruiz J, Sanchez-Sanchez B. Bronchocentric granulomatosis as a first clinical manifestation in an adult patient with p67phox deficiency. Respiration. 1999;66:547-550.
13. Lukela M, DeGuzman D, Weinberger S, Saint S. Clinical problem-solving: unfashionably late. N Engl J Med. 2005;352:64-69.
14. Hatanaka E, Carvalho BT, Condino-Neto A, Campa A. Hyperresponsiveness of neutrophils from gp91phox deficient patients to lipopolysaccharide and serum amyloid-A. Immun Lett. 2004;94:43-46.
15. Kasahara Y, Iwai K, Yachie A, et al. Involvement of reactive oxygen intermediates in spontaneous and CD95-mediated apoptosis of neutrophils. Blood. 1997;5:1748-1753.
16. Rada BK, Geiszt M, Van Bruggen R, Nemet K, Roos D, Ligeti E. Calcium signalling is altered in myeloid cells with a deficiency in NADPH oxidase activity. Clin Exp Immunol. 2003;132:53-60.
17. Tintinger GR, Theron AJ, Steel HC, Anderson R. Accelerated calcium influx and hyperactivation of neutrophils in chronic granulomatous disease. Clin Exp Immunol. 2001;123:254-263.
18. Lekstrom-Himes J, Kuhns DB, Alvord WG, Gallin JI. Inhibition of human neutrophil IL-8 production by hydrogen peroxide and dysregulation in chronic granulomatous disease. J Immunol. 2005;174:411-417.
19. Thwaites GE, Nguyen DB, Nguyen HD, et al. Dexamethasone for the treatment of tuberculous meningitis in adolescents and adults. N Engl J Med. 2004;351:1741-1751.
20. Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DI. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. QJM. 2004;8:525-535.
21. Mall RK, Agarwal A, Garg RK, Kar AM, Shukla R. Short course of prednisolone in Indian patients with solitary cysticercus granuloma and new-onset seizures. Epilepsia. 2003;44:1397-1401.
22. Lerdluedeeporn P, Krogstad P, Roberts RL, Stichm ER. Oral steroids in cat-scratch disease. Clin Pediatr. 2003;42:71-73.
23. Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med. 2004;350:2487-2498.
24. Keh D, Sprung CL. Use of corticosteroid therapy in patients with sepsis and septic shock: an evidence-base review. Crit Care Med. 2004;32(suppl):S527- S533.